BF2.649 (Pitolisant)

BF2.649 (Pitolisant)
Trade Name
Orphan Indication Narcolepsy
USA Market Approval USA
USA Designation Date 2010-05-17 00:00:00
Sponsor Bioprojet Pharma;9, rue Rameau;Paris